Thus, we collected morning midstream urine from 4 lung cancer patients positive for the Kras mutation and from 4 age- and gender-matched healthy controls (detailed information on the patients and controls is provided in Fig. 3A). The gene discussed is KRAS; the disease is lung carcinoma.